Free Trial

Telsey Advisory Group Forecasts Zevia PBC FY2024 Earnings

Zevia PBC logo with Consumer Staples background

Zevia PBC (NYSE:ZVIA - Free Report) - Analysts at Telsey Advisory Group lowered their FY2024 EPS estimates for shares of Zevia PBC in a research note issued on Tuesday, January 14th. Telsey Advisory Group analyst D. Telsey now expects that the company will post earnings per share of ($0.30) for the year, down from their previous estimate of ($0.27). Telsey Advisory Group has a "Market Perform" rating and a $4.00 price objective on the stock. The consensus estimate for Zevia PBC's current full-year earnings is ($0.30) per share. Telsey Advisory Group also issued estimates for Zevia PBC's Q4 2024 earnings at ($0.07) EPS, Q1 2025 earnings at ($0.05) EPS, Q4 2025 earnings at ($0.03) EPS, FY2025 earnings at ($0.16) EPS and FY2026 earnings at ($0.09) EPS.

Zevia PBC (NYSE:ZVIA - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.07. The company had revenue of $36.37 million during the quarter, compared to analyst estimates of $38.53 million. Zevia PBC had a negative net margin of 14.02% and a negative return on equity of 38.02%. During the same quarter in the previous year, the business posted ($0.16) EPS.

Separately, The Goldman Sachs Group upped their price target on Zevia PBC from $1.15 to $3.75 and gave the stock a "neutral" rating in a research note on Tuesday.

View Our Latest Research Report on ZVIA

Zevia PBC Price Performance

Shares of ZVIA stock traded up $0.40 on Thursday, reaching $4.81. 1,464,834 shares of the company were exchanged, compared to its average volume of 1,333,923. The company has a 50-day moving average of $3.08 and a 200-day moving average of $1.72. The company has a market cap of $350.81 million, a price-to-earnings ratio of -12.64 and a beta of 0.66. Zevia PBC has a one year low of $0.62 and a one year high of $4.94.

Insider Transactions at Zevia PBC

In related news, Director Rosemary L. Ripley sold 2,567,006 shares of Zevia PBC stock in a transaction that occurred on Thursday, December 5th. The stock was sold at an average price of $1.90, for a total transaction of $4,877,311.40. Following the transaction, the director now owns 2,719,258 shares of the company's stock, valued at $5,166,590.20. The trade was a 48.56 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 12.55% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Zevia PBC

Several large investors have recently bought and sold shares of ZVIA. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Zevia PBC in the 2nd quarter worth $26,000. Nwam LLC purchased a new position in Zevia PBC during the third quarter worth about $39,000. Renaissance Technologies LLC boosted its holdings in Zevia PBC by 128.7% during the second quarter. Renaissance Technologies LLC now owns 69,300 shares of the company's stock worth $47,000 after purchasing an additional 39,000 shares during the last quarter. XTX Topco Ltd bought a new stake in Zevia PBC in the 3rd quarter worth about $50,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Zevia PBC in the 3rd quarter valued at about $108,000. 53.21% of the stock is currently owned by institutional investors.

About Zevia PBC

(Get Free Report)

Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.

Recommended Stories

Should You Invest $1,000 in Zevia PBC Right Now?

Before you consider Zevia PBC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zevia PBC wasn't on the list.

While Zevia PBC currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines